ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Living donor"

  • 2022 American Transplant Congress

    Living Donor Liver Transplantation: A Better Option for Patients 70 Years or Older

    A. Ganoza, A. Duarte-Rojo, V. Gunabushanam, M. Molinari, S. Ganesh, D. Reddy, A. M. Thompson, A. Tevar, C. Hughes, A. Humar

    University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: The burden of liver diseases in patients of advanced age has risen. Irrespective of its possible causes, older recipients have a higher waitlist mortality…
  • 2022 American Transplant Congress

    Patient-Reported Barriers to Living Kidney Donor Follow-Up

    B. Orandi, R. Reed, H. Qu, G. Owens, S. Brooks, C. Killian, V. Kumar, S. Sheikh, R. Cannon, C. Lewis, J. Locke

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Despite regulations mandating follow-up laboratory testing for living kidney donors, less than half of transplant centers are in compliance. We sought to understand barriers…
  • 2022 American Transplant Congress

    Variation in Adult Living Donor Liver Transplantation in the United States: Identifying Opportunities for Increased Utilization

    K. Lentine1, D. Axelrod2, M. Schnitzler1, R. Li1, M. Dew3, T. Bitterman4, K. Olthoff4, J. Locke5, S. Emre6, H. Hunt7, T. Tanaka2, A. Liapakis6

    1Saint Louis University, St. Louis, MO, 2U Iowa, Iowa City, IA, 3U Pittsburgh, Pittsburgh, PA, 4U Penn, Philadelphia, PA, 5UAB, Birmingham, AL, 6Yale, New Haven, CT, 7UNOS, Richmond, VA

    *Purpose: To assess barriers to living donor liver transplant (LDLT) access in light of convincing evidence of survival benefits for patients with end-stage liver disease.*Methods:…
  • 2022 American Transplant Congress

    Robotic Living Donor Nephrectomy: The Future is Now

    J. Yu, N. Vaccharajani, S. Matson, M. Scherer, J. Wellen, S. Shenoy, W. Chapman, M. Doyle, A. Khan

    Surgery, Washington University School of Medicine, St. Louis, MO

    *Purpose: Living donor kidney transplants represent nearly 25% of all kidney transplants performed in the United States. Over the last 10 years, an increasing emphasis…
  • 2022 American Transplant Congress

    Effectiveness of a Targeted Media Campaign on Engagement and Interest in Living Donation

    L. A. Davis1, A. Livingston2, A. Waterman3

    1Houston Methodist Hospital, J.C. Walter Jr Transplant Center, Houston, TX, 2Multiview, Irving, TX, 3Transplant Research and Education Center, Houston, TX

    *Purpose: Living donation rates have continued to decline. Research has suggested that disseminating living donation education and information more broadly to larger audiences outside of…
  • 2022 American Transplant Congress

    Identification of a Donor Kidney with Heterozygous COL4A3-related Alport Syndrome in a Homozygous Recipient Highlighting the Importance of Genetic Testing

    K. Alrejjal1, U. Abdullatif1, L. Beretich2, H. Tabriziani2, A. Abdellatif3

    1CLS Health, Webster, TX, 2Natera, Inc., Austin, TX, 3Baylor College of Medicine, Houston, TX

    *Purpose: Selection of an appropriate donor for kidney transplantation can mitigate the risk of rejection and increase the chances of graft survival. While immunologic matching…
  • 2022 American Transplant Congress

    Interaction Between Financial Barriers and Other Motivators, Barriers, and Facilitators of Living Organ Donation

    A. R. Smith1, R. J. Mandell1, M. E. Helmuth1, N. P. Goodrich1, J. B. Wiseman1, K. A. Gifford2, M. A. Fava1, A. O. Ojo3, R. M. Merion1, A. K. Mathur4

    1Arbor Research Collaborative for Health, Ann Arbor, MI, 2American Society for Transplant Surgeons, Arlington, VA, 3University of Kansas Medical Center, Kansas City, KS, 4Mayo Clinic, Phoenix, AZ

    *Purpose: Our objective was to assess how financial barriers to living donation interact with other motivators, barriers, and facilitators during the decision-making process.*Methods: Data were…
  • 2022 American Transplant Congress

    National Landscape of the Utilization of Living Donor Liver Allografts in Redo Liver Transplantation

    J. I. López, K. Nijhar, J. Mitchell, L. Bowles Zeiser, K. Key, A. Asamoah-Mensah, A. Thomas, R. Haneda, S. K. Romano, J. Huang, A. Massie, A. M. Cameron, D. L. Segev, E. A. King

    Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: To examine the use of living donor liver allografts in patient’s requiring redo liver transplantation.*Methods: Using data from SRTR 2009-2020, we evaluated the number…
  • 2022 American Transplant Congress

    Selection of the Recipient Artery Used for Arterial Reconstruction in Living Donor Liver Transplantation: Does It Impact Biliary Reconstruction Outcomes

    A. M. Elsabbagh, A. M. Sultan, A. Marwan, A. Shehta, T. Salah, M. Elshobary, A. Monier, M. Eldesoky, R. Said, M. Elmorshedi, W. Elsarraf, A. Yassen, O. Fathy, M. Abdel Wahab

    Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura, Egypt

    *Purpose: Impact of level and laterality of the recipient hepatic artery used for arterial reconstruction in living donor liver transplantation on the outcomes of biliary…
  • 2022 American Transplant Congress

    Domino Living Donor Kidney Transplant Following Therapeutic Nephrectomy for Renal Artery Stenosis with Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series

    R. Pearson1, J. Wubetu1, K. Stevenson1, E. Aitken1, A. Jackson1, M. Clancy2, D. B. Kingsmore1

    1Renal Transplant, Queen Elizabeth University Hospital, Glasgow, Glasgow, United Kingdom, 2Renal Transplantation, Queen Elizabeth University Hospital, Glasgow, United Kingdom

    *Purpose: Ex vivo normothermic perfusion (EVNP) is increasingly recognized as a viability tool to increase organ utilization. We report use of EVNP to assess graft…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 27
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences